Fagoterapia LAB S.r.l.

[#I4ID2024] – 📢 The track on #alternatives to current #antibiotics has started at the 8th edition of the I4ID Congress chaired by Francesca Bernardini from Evotec and Sebastien Coyne from AUROBAC THERAPEUTICS ! 👉With Giuseppe Maccari from Fagoterapia LAB S.r.l. in Italy talking about the application of phage therapy in infectious diseases 👉With Urs Jenal from Biozentrum, University of Basel presenting on a new human Lung Tissue model to study Pseudomonas aeruginosa infection and treatment 👉With Yves Briers from Obulytix in Belgium that talked about the use of #PhageLysins for transformatve innovation of the #antibioticmarket co-organized by Lyonbiopôle Auvergne-Rhône-Alpes and MabDesign Network With the support of Métropole de Lyon and Région Auvergne-Rhône-Alpes #infectiousdiseases #immunotherapy #innovation #biotech #antimicrobialResistance #AMR

I was honored to be part of the 8th edition of the I4ID Congress, where I had the opportunity to present the work we are doing at Fagoterapia LAB S.r.l. on the application of phage therapy in infectious diseases. This session on alternatives to antibiotics highlighted groundbreaking approaches to combating infectious diseases. Sharing the stage with incredible researchers like Yves Briers and Urs Jenal. The discussion underscored the urgency of tackling antimicrobial resistance (#AMR) and showcased innovative therapies paving the way for the future.

Post-doc position on phage therapy at University of Pisa in Dr Mariagrazia Di Luca team. For more info, please check below English and Italian forms in the link

🆕💥 Dopo un lungo processo di selezione, nazionale e poi della European Commission 🇪🇺, siamo orgogliosi che Fagoterapia LAB S.r.l. risulti tra le 5 aziende italiane 🔝insieme a Takis, Holostem S.r.l. Sanofi e #Nurex a prendere parte al progetto #Med4cure e poter accedere ai finanziamenti del fondo #IPCEI salute, Importanti Progetti di Comune Interesse Europeo. 🚀 Grazie a questi finanziamenti ed al supporto del Ministero delle Imprese e del Made in Italy svilupperemo il nostro progetto #Phages4All per portare la terapia a base di #batteriofagi ai pazienti con infezioni da batteri resistenti agli antibiotici e/o difficili da trattare. Nel nostro progetto saranno coinvolti 4 partner diretti di IPCEI, 2 associati e più di 20 partner indiretti tra aziende, ospedali e centri di ricerca nazionali ed europei. 👉 https://bit.ly/4bAk5FS 👉 https://lnkd.in/eVKzrgFu After a long selection process, national 🇮🇹 and by the European Commission 🇪🇺, we are proud that fagoterapia lab results among the 5 Italian companies 🔝 together with Takis, Holostem, Sanofi, and Nurex to take part to the #Med4cure project and to access funding from the #IPCEI health fund, Important Projects of Common European Interest.🚀 Thanks to such State aid we will be able to develop our #Phages4All project to bring bacteriophage therapy to patients with antibiotic-resistant and/or difficult-to-treat bacterial infections. In our project we will involve 4 direct partners from IPCEI, two associate partners and more than 20 indirect partners from national and European companies, hospitals and research centers. 👉 https://bit.ly/4bAk5FS 👉 https://lnkd.in/eVKzrgFu Mariagrazia Di Luca Novella Cesta Giuseppe Maccari Stefano Cheli #phagetherapy #stopAMR

Glad to be listed this year among the top10 Italian startups founded by women. Thanks SheTech for mentioning!